Compare AORT & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AORT | INNV |
|---|---|---|
| Founded | 1984 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 1996 | 2021 |
| Metric | AORT | INNV |
|---|---|---|
| Price | $27.23 | $11.07 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 1 |
| Target Price | ★ $49.40 | $7.00 |
| AVG Volume (30 Days) | ★ 550.4K | 246.1K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.62 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | $298,836,000.00 | ★ $853,699,000.00 |
| Revenue This Year | $14.20 | $12.85 |
| Revenue Next Year | $11.20 | $8.88 |
| P/E Ratio | $886.00 | ★ N/A |
| Revenue Growth | ★ 18.01 | 11.76 |
| 52 Week Low | $19.16 | $3.18 |
| 52 Week High | $48.25 | $12.64 |
| Indicator | AORT | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 57.36 | 48.74 |
| Support Level | $19.49 | $10.93 |
| Resistance Level | $37.65 | $12.63 |
| Average True Range (ATR) | 0.95 | 0.58 |
| MACD | 0.01 | -0.17 |
| Stochastic Oscillator | 54.28 | 31.41 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.